Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceuticals	1.68B	1.20B	1.02B	1.02B	996.22M
Pharmaceuticals Growth	40.07%	17.71%	-0.31%	2.68%	28.14%
Total	1.68B	1.20B	1.02B	1.02B	996.22M
Total Growth	40.07%	17.71%	-0.31%	2.68%	28.14%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
East China	408.59M	316.78M	288.81M	331.94M	336.97M
East China Growth	28.98%	9.69%	-12.99%	-1.49%	6.30%
Central China	345.41M	253.37M	213.86M	217.75M	192.61M
Central China Growth	36.32%	18.47%	-1.78%	13.05%	31.15%
South China	251.57M	209.59M	186.08M	202.80M	211.25M
South China Growth	20.03%	12.64%	-8.24%	-4.00%	90.87%
North China	307.65M	174.97M	125.20M	85.87M	76.87M
North China Growth	75.83%	39.75%	45.80%	11.71%	13.12%
Southwest China	88.46M	87.90M	86.64M	89.94M	86.68M
Southwest China Growth	0.63%	1.46%	-3.66%	3.75%	44.36%
Northwest China	58.56M	41.70M	41.65M	39.05M	33.87M
Northwest China Growth	40.44%	0.11%	6.67%	15.28%	59.31%
Northeast China	61.10M	52.62M	52.72M	43.36M	45.10M
Northeast China Growth	16.11%	-0.20%	21.59%	-3.85%	-9.57%
Export	159.91M	63.39M	24.79M	12.20M	12.87M
Export Growth	152.26%	155.71%	103.19%	-5.17%	240.07%
Total	1.68B	1.20B	1.02B	1.02B	996.22M
Total Growth	40.07%	17.71%	-0.31%	2.68%	28.14%

Source: S&P Global Market Intelligence.